News
NHS to offer Wegovy to a million more people in England
The NHS in England will make Novo Nordisk's Wegovy available to around 1.2m people in order to reduce their risk of heart attacks and strokes.
Sales & Marketing
Sponsored
Using AI-driven synthetic personas to take your insights fur...
As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
Market Access
12 questions with: Daniel Kohlstaedt
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
Sales & Marketing
Sponsored
What HCPs Say Pharma Gets Wrong About Survey Research
Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.
Digital
Creating what nature has not from AI and computational molec...
Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.
Sales & Marketing
Sponsored
The strategic imperative of Integrated Evidence Generation P...
Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.
R&D
Partner Content
Emerging Trends in Personalised Medicine at PHARMAP 2026
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
R&D
Partner Content
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines